Letters
Government regulation is needed to prevent biased under-reporting of clinical trials
BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7463.462-a (Published 19 August 2004) Cite this as: BMJ 2004;329:462
- Iain Chalmers, editor, James Lind Library (ichalmers@jameslindlibrary.org)
- James Lind Initiative, Oxford OX2 7LG
EDITOR—In 1996, Schering Healthcare published details of its ongoing randomised clinical trials in the Cochrane Library. The chief executive told me that he was doing this because industry's failure to disclose the results of its phase 3 trials could not be defended ethically or scientifically. Two years later, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.